Terms: = Ovarian cancer AND BRIP1, MGC126521, 83990, ENSG00000136492, FANCJ, FLJ90232, Q9BX63, MGC126523, OF
1100 results:
1. Purification and biochemical characterization of the G4 resolvase and DNA helicase fancj.
Kulikowicz T; Sommers JA; Fuchs KF; Wu Y; Brosh RM
Methods Enzymol; 2024; 695():1-27. PubMed ID: 38521581
[TBL] [Abstract] [Full Text] [Related]
2. Cost-Effectiveness of Gene-Specific Prevention Strategies for ovarian and Breast cancer.
Wei X; Sun L; Slade E; Fierheller CT; Oxley S; Kalra A; Sia J; Sideris M; McCluggage WG; Bromham N; Dworzynski K; Rosenthal AN; Brentnall A; Duffy S; Evans DG; Yang L; Legood R; Manchanda R
JAMA Netw Open; 2024 Feb; 7(2):e2355324. PubMed ID: 38334999
[TBL] [Abstract] [Full Text] [Related]
3. The Dairy and cancer Controversy: Milking the Evidence.
Scialo TE; Pace CM; Abrams DI
Curr Oncol Rep; 2024 Mar; 26(3):191-199. PubMed ID: 38289521
[TBL] [Abstract] [Full Text] [Related]
4. PARP Inhibitors in Breast cancer: a Short Communication.
Daly GR; AlRawashdeh MM; McGrath J; Dowling GP; Cox L; Naidoo S; Vareslija D; Hill ADK; Young L
Curr Oncol Rep; 2024 Feb; 26(2):103-113. PubMed ID: 38236558
[TBL] [Abstract] [Full Text] [Related]
5. Myricetin, a natural inhibitor of CD147, increases sensitivity of cisplatin in ovarian cancer.
Chen L; Fan T; Wang M; Zhu CY; Feng WY; Li Y; Yang H
Expert Opin Ther Targets; 2024; 28(1-2):83-95. PubMed ID: 38235574
[TBL] [Abstract] [Full Text] [Related]
6. Danggui Shaoyao San protects cyclophosphamide-induced premature ovarian failure by inhibiting apoptosis and oxidative stress through the regulation of the SIRT1/p53 signaling pathway.
Chen H; Zhang G; Peng Y; Wu Y; Han X; Xie L; Xu H; Chen G; Liu B; Xu T; Pang M; Hu C; Fan H; Bi Y; Hua Y; Zhou Y; Luo S
J Ethnopharmacol; 2024 Apr; 323():117718. PubMed ID: 38181933
[TBL] [Abstract] [Full Text] [Related]
7. Early ovarian cancer Detection in the Age of Fallopian Tube Precursors: A Systematic Review.
Greenwood A; Woodruff ER; Nguyen C; Piper C; Clauset A; Brubaker LW; Behbakht K; Bitler BG
Obstet Gynecol; 2024 Mar; 143(3):e63-e77. PubMed ID: 38176019
[TBL] [Abstract] [Full Text] [Related]
8. The evolving landscape of antibody-drug conjugates in ovarian cancer: new drugs for a new era.
García-Illescas D; Mazzeo R; García-Durán C; Oaknin A
Curr Opin Obstet Gynecol; 2024 Apr; 36(2):104-111. PubMed ID: 38170620
[TBL] [Abstract] [Full Text] [Related]
9. A review of racial disparities in ovarian cancer and clinical trials.
Ali M; Tewari KS
Curr Opin Obstet Gynecol; 2024 Feb; 36(1):23-27. PubMed ID: 38170549
[TBL] [Abstract] [Full Text] [Related]
10. Maintenance therapy for newly and recurrent epithelial ovarian cancer: current therapies and future perspectives.
Salutari V; Giudice E; Lorusso D
Curr Opin Obstet Gynecol; 2024 Feb; 36(1):9-17. PubMed ID: 38170548
[TBL] [Abstract] [Full Text] [Related]
11. Endometriosis-related infertility: severe pain symptoms do not impact assisted reproductive technology outcomes.
Maignien C; Bourdon M; Parpex G; Ferreux L; Patrat C; Bordonne C; Marcellin L; Chapron C; Santulli P
Hum Reprod; 2024 Feb; 39(2):346-354. PubMed ID: 38142239
[TBL] [Abstract] [Full Text] [Related]
12. Suicide gene delivery by morphology-adaptable enantiomeric peptide assemblies for combined ovarian cancer therapy.
Song N; Sun Z; Wang B; Liu X; Hu B; Chen N; Zhang S; Yu Z
Acta Biomater; 2024 Feb; 175():250-261. PubMed ID: 38122884
[TBL] [Abstract] [Full Text] [Related]
13. Early-Onset ovarian cancer <30 Years: What Do We Know about Its Genetic Predisposition?
Horackova K; Janatova M; Kleiblova P; Kleibl Z; Soukupova J
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069345
[TBL] [Abstract] [Full Text] [Related]
14. Genome-wide association study meta-analysis of dizygotic twinning illuminates genetic regulation of female fecundity.
Mbarek H; Gordon SD; Duffy DL; Hubers N; Mortlock S; Beck JJ; Hottenga JJ; Pool R; Dolan CV; Actkins KV; Gerring ZF; Van Dongen J; Ehli EA; Iacono WG; Mcgue M; Chasman DI; Gallagher CS; Schilit SLP; Morton CC; Paré G; Willemsen G; Whiteman DC; Olsen CM; Derom C; Vlietinck R; Gudbjartsson D; Cannon-Albright L; Krapohl E; Plomin R; Magnusson PKE; Pedersen NL; Hysi P; Mangino M; Spector TD; Palviainen T; Milaneschi Y; Penninnx BW; Campos AI; Ong KK; Perry JRB; Lambalk CB; Kaprio J; Ólafsson Í; Duroure K; Revenu C; Rentería ME; Yengo L; Davis L; Derks EM; Medland SE; Stefansson H; Stefansson K; Del Bene F; Reversade B; Montgomery GW; Boomsma DI; Martin NG
Hum Reprod; 2024 Jan; 39(1):240-257. PubMed ID: 38052102
[TBL] [Abstract] [Full Text] [Related]
15. Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival.
Kahn RM; Selenica P; Boerner T; Roche KL; Xiao Y; Sia TY; Maio A; Kemel Y; Sheehan M; Salo-Mullen E; Breen KE; Zhou Q; Iasonos A; Grisham RN; O'Cearbhaill RE; Chi DS; Berger MF; Kundra R; Schultz N; Ellenson LH; Stadler ZK; Offit K; Mandelker D; Aghajanian C; Zamarin D; Sabbatini P; Weigelt B; Liu YL
Gynecol Oncol; 2024 Jan; 180():35-43. PubMed ID: 38041901
[TBL] [Abstract] [Full Text] [Related]
16. Laparoscopic ovarian-Sparing Surgery for the Management of Benign ovarian Lesions in Pediatric Patients: A Retrospective Analysis.
Piotrowska-Gall A; Strzelecka A; Wróbel J; Salamon A; Urbaniak-Wąsik S; Cierniak P; Wolak P
J Pediatr Surg; 2024 Mar; 59(3):400-406. PubMed ID: 37980197
[TBL] [Abstract] [Full Text] [Related]
17. Contemporary Trends in Laparoscopy and ovarian Sparing Surgery for ovarian Torsion in the Pediatric Population.
Huerta CT; Rodriguez C; Parreco J; Thorson CM; Sola JE; Perez EA
J Pediatr Surg; 2024 Mar; 59(3):393-399. PubMed ID: 37968152
[TBL] [Abstract] [Full Text] [Related]
18. Two-pronged microenvironmental modulation of metal-oxidase cascade catalysis and metabolic intervention for synergistic tumor immunotherapy.
Song Q; Gao H; Sun S; Li Y; Wu X; Yang J; Wang B; Zhang Y; Wang L
Acta Biomater; 2024 Jan; 173():378-388. PubMed ID: 37925121
[TBL] [Abstract] [Full Text] [Related]
19. Development and validation of an individualized gene expression-based signature to predict overall survival of patients with high-grade serous ovarian carcinoma.
Yuan D; Zhu H; Wang T; Zhang Y; Zheng X; Qu Y
Eur J Med Res; 2023 Oct; 28(1):465. PubMed ID: 37884970
[TBL] [Abstract] [Full Text] [Related]
20. Research progress on traditional Chinese medicine-induced apoptosis signaling pathways in ovarian cancer cells.
Wang Y; Xie L; Liu F; Ding D; Wei W; Han F
J Ethnopharmacol; 2024 Jan; 319(Pt 2):117299. PubMed ID: 37816474
[TBL] [Abstract] [Full Text] [Related]
[Next]
